Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer. - Wikidata - awgldk - TriplyDB

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer.

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer.

http://www.wikidata.org/entity/Q42954285

about

Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis Towards the introduction of the 'Immunoscore' in the classification of malignant tumours An immunologic portrait of cancer Immunotherapy for Gastroesophageal Cancer Immunotherapy as a Potential Treatment for Chordoma: a Review.Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers: a meta analysis Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival.Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.Cancer immunology--analysis of host and tumor factors for personalized medicine.High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer Trial watch: Prognostic and predictive value of the immune infiltrate in cancer Prognostic value of colorectal cancer biomarkers.Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.Arsenic trioxide inhibits lung metastasis of mouse colon cancer via reducing the infiltration of regulatory T cells.Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.Cell surface markers in colorectal cancer prognosis.Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI.Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer.Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor.Ontogeny of Tumor-associated CD4+CD25+Foxp3+ T-regulatory Cells.An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis.Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3+ cells in tumour infiltrate.Tumor-infiltrating memory T-lymphocytes for prognostic prediction in cancer patients: a meta-analysis Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women.Computer-assisted stereology and automated image analysis for quantification of tumor infiltrating lymphocytes in colon cancer.Tumor-infiltrating CD8(+) T lymphocytes associated with clinical outcome in anal squamous cell carcinoma.A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).Tumor-infiltrating CD45RO+ Memory T Lymphocytes Predict Favorable Clinical Outcome in Solid Tumors.Tumor-infiltrating CD45RO(+) memory cells are associated with a favorable prognosis breast cancer.Characterization of an adaptive immune response in microsatellite-instable colorectal cancer.Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.Tumor-infiltrating FoxP3+ Tregs predict favorable outcome in colorectal cancer patients: A meta-analysis.The Clinicopathological and Prognostic Implications of FoxP3+ Regulatory T Cells in Patients with Colorectal Cancer: A Meta-Analysis.

P2860

Q26783675-8106BD9B-70E0-412C-935D-8F917BC6C401 Q27024810-474BAED5-7CE4-4716-B20F-861A0E11D653 Q27026489-8C9B884E-6D36-4E27-9878-826F7740CA6E Q27028000-280CD2C1-4B10-4AAD-905B-6D18C67C76C5 Q28069873-AE73F93C-1596-475C-AE2D-CF52C7C4B479 Q33276143-593D58A1-D523-49EB-B53D-66C336C1D9A4 Q33609920-FB6750CD-D432-4AB5-9067-6242A7381CC3 Q33818673-174E33DF-E158-4BA0-AE84-FF505411A041 Q34551974-6766AD97-1131-48E1-A285-3EA5DE7FE4CB Q34575227-66282CE7-2B42-49C3-A04E-B2A3DC45041D Q35433402-E2E25235-585B-4FE0-A8EB-D048B83D2D8A Q35541507-DF03CE00-9529-4A75-B719-EB416C717754 Q35550879-60262A59-D4D6-4B90-8422-5C30AE3C330A Q35583180-7463EFFD-01BB-4CA3-8BDD-61BAB72A4707 Q36014349-02271D6C-DCC1-4988-93E4-1823C8F916C4 Q36456483-0D63DAE2-3294-4356-BF70-A509893F61D7 Q37132721-C03E72FE-59CF-4158-BAD4-47E2D27C8DB8 Q37280390-96177D9B-82F2-4169-8A7D-B9DFAC0BFB0C Q37447671-C49994D3-6AF0-4908-B229-B5E12D61BA89 Q37697218-825781E1-AC3B-4F23-9716-2E0C10341B4D Q37845669-A760E39B-CD33-41ED-94EB-F73F3E769960 Q37880662-E7C8B9E5-D803-4465-BED8-0F3E1E51B9DF Q37885285-18833938-05C1-4B60-8028-68C48D097CBE Q37945304-CFC776CE-8E3E-442B-B56B-748A26B8F22C Q38327236-5586FD12-D04C-4FB0-A9A9-11F7FCAD1735 Q38412549-AEC7B555-B657-4EC7-88E1-6B5F6B7CAA79 Q38985262-83BE94D7-74B3-4AE3-A9ED-B34CB07B3AC7 Q39327275-FDFE92E0-6225-40D7-9935-F98BBE402152 Q39359136-5FAC484E-024F-40FF-B000-142A425E23AF Q39777761-9FD65604-5F9B-4BAF-A41F-6F788B3977B9 Q40423175-502ACAB1-DD63-48CD-BF0E-98B004BB2FD9 Q40500354-F3FB7CD8-B656-4E07-83DA-DF2A42341575 Q41044428-560291EF-61A2-4C0B-8062-00F4BA235DCE Q41126888-FAB95831-7E7D-417B-ABD5-70F1F5F90724 Q41606742-E6A3C9F2-D0C5-4B4B-AECC-7E4B4A8AA2CF Q41673328-FF5CE7B2-4A6A-4F63-9B34-8E01488DF7E4 Q41905990-82DFB4B0-FF3F-4A14-A9E6-CAF9A1F506A1 Q45362166-45B89437-509E-4AD4-87BA-74350CCA04B3 Q46479553-1988197A-6486-47B6-998C-2213049D5A33 Q47101966-0CDD4E1C-57C2-47BD-98A8-14C730BD0CD3

P2860

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer.

http://www.wikidata.org/entity/Q42954285

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer.

@en

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer.

@nl

type

label

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer.

@en

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer.

@nl

prefLabel

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer.

@en

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer.

@nl

P1433

Q42954285-72287E4F-C899-48C9-BA2C-52AA4C312C74

P1476

Q42954285-260B45BE-B7C6-42E1-BED6-F179F54EDE7A

P2093

Q42954285-5AC1BAA8-6B19-4B88-9C9B-C145A44C44BB

Q42954285-856FC1C3-A3F6-4DDB-9095-AFEF2AF49C1D

Q42954285-C40F996A-71E0-49B5-8DB2-333267D75553

Q42954285-C4C3B26B-7A50-4221-B7C8-358330E40104

Q42954285-DBF998D7-7166-405B-B120-CC472BA05DF7

P2860

Q42954285-1092E635-0238-46DF-B8F8-1D256E708119

Q42954285-15A1E0EC-C08B-4445-9E99-160927C28CA7

Q42954285-1796C052-440A-4F16-9454-C5439C3CD74B

Q42954285-25D5922A-91B8-4674-80EF-E1963F2CD296

Q42954285-2BF85D17-FEC8-47E7-8DC7-EF96F4D24977

Q42954285-39102C41-068D-435B-A1A9-4900D55AA08D

Q42954285-3FC5B89E-0E38-451C-8344-5532AD54529E

Q42954285-4434061E-1592-432E-8393-03F6AA1CFFB0

Q42954285-48ED2AB0-EF90-4134-8B7F-1634AABE893A

Q42954285-5D4DE744-CE5D-4FC9-86B0-D4E8A7917BA8

P304

Q42954285-6B5C2CB8-F512-41C1-AD61-4CC1039D7A3A

P31

Q42954285-C500EC3B-901C-46AC-9051-A40F14881846

P356

Q42954285-87AD3A8A-2787-457E-9D49-BFF1305C3411

P407

Q42954285-38C0D73E-6921-47FC-AF16-4C7D1FB75E96

P433

Q42954285-420BC005-0813-4540-95B3-EDA9E8BFCBB0

P478

Q42954285-CC688F5F-B6B6-4EF5-880A-DCA5AF2CFF61

P577

Q42954285-F3A6ED83-D875-4F03-BE0C-F8AEA521783D

P5875

Q42954285-1A3E8B4C-2039-4539-9AB6-77B6FE14B1C7

P698

Q42954285-01A12A6A-0292-4A1B-9F93-437EF5D1AF0C

P356

P1433

P1476

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer.

@en

P2093

Ho-Kyung Chun

http://www.w3.org/2001/XMLSchema#string

Sanghui Park

http://www.w3.org/2001/XMLSchema#string

Seong Hyeon Yun

http://www.w3.org/2001/XMLSchema#string

Won-Suk Lee

http://www.w3.org/2001/XMLSchema#string

Woo Yong Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.

Effector memory T cells, early metastasis, and survival in colorectal cancer.

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group.

Foxp3: a critical regulator of the development and function of regulatory T cells.

FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.

P304

5188-5199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.25293

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45390421

http://www.w3.org/2001/XMLSchema#string

P698

20665489

http://www.w3.org/2001/XMLSchema#string